SB

Sivakumar Balakrishnan Nair Leela

Active Director Director DIN 11192496
DIN 11192496 First appointment Jul 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sivakumar Balakrishnan Nair Leela

Data last updated:

Sivakumar Balakrishnan Nair Leela is a Director at Metrolabs Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11192496
Primary Designation Director
Industry Pharma
First Appointment 08 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Jul 20252025Active

Board colleagues of Sivakumar Balakrishnan Nair Leela

NameDINCompanyDesignation
Indira Dinamol11192497Metrolabs Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Metrolabs Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sivakumar Balakrishnan Nair Leela

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sivakumar Balakrishnan Nair Leela

Sivakumar Balakrishnan Nair Leela currently holds 1 directorship: Metrolabs Pharmaceuticals Private Limited (Director, since 08 Jul 2025).

Sivakumar Balakrishnan Nair Leela was first appointed on 08 Jul 2025 as Director at Metrolabs Pharmaceuticals Private Limited.

The current boards of Sivakumar Balakrishnan Nair Leela's companies include Indira Dinamol (Metrolabs Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available